Mercer International (MERC) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

MERC Mercer International

Watchlist

7.850
-0.070-0.88%

Close Jul 29 16:00 ET

524.77MMarket Cap-2281P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Mercer International Inc : TD Cowen Cuts Target Price to $9 From $11
ReutersJul 23 08:08 ET
Mercer International Inc. Announces Conference Call for Second Quarter 2024 Results
Mercer InternationalJul 23 00:00 ET
CIBC Maintains Mercer International(MERC.US) With Hold Rating, Cuts Target Price to $10
Moomoo NewsJul 18 11:32 ET · Ratings
Express News | Mercer International Inc : CIBC Cuts Target Price to $10 From $11
ReutersJul 18 00:49 ET
Mercer International Inc. Receives Improved ESG Risk Rating From Sustainalytics
Mercer InternationalJul 17 00:00 ET
RBC Lowers Price Target on Mercer International to $10 From $11, Maintains Sector Perform Rating
MT NewswiresJul 11 06:40 ET

Comments

Moomoo AI

Mar 6 07:21

Mercer's acquisition of MDK is a strategic move to bolster its services for ultrahigh-net-worth clients, a rapidly expanding segment. The deal also aims to broaden Mercer's footprint in the Pacific Northwest market.

Mercer Makes Ultrahigh-Net-Worth Play With Acquisition of $2.5 Billion Seattle Firm -- Barrons.com

Moomoo AI

Dec 6, 2023 08:49

The fall in revenue and lack of profitability for Mercer International contribute to a pessimistic market viewpoint. However, the company's substantial dividend payments paint a more comprehensive picture, when considering total shareholder return.

Shareholders in Mercer International (NASDAQ:MERC) Have Lost 33%, as Stock Drops 8.1% This Past Week

Analysts Notebook

Jul 6, 2022 07:10

Columns Top upgrades and downgrades on 7/6: MRK, EOG, ABT, UNP and more

Upgrades
• $A.O. Smith(AOS.US)$ : Longbow Research Upgrades to Buy from Neutral - PT $71
• $Callon Petroleum(CPE.US)$ : RBC Upgrades to Outperform from Sector Perform - PT $75
• $Dun & Bradstreet(DNB.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $17 (from $16)
• $Enanta Pharmaceuticals(ENTA.US)$ : Evercore ISI Upgrades to Outperform from In Line - PT $62 (from $39)
• $Corning(GLW.US)$ : CFRA Upgrades to Strong Buy ...

Hucktosoar

Jan 7, 2022 05:08

$Mercer International(MERC.US)$ The head of India's leading medical research institute said on Wednesday that Mercer's new oral crown drug molnupiravir has "significant safety issues" that may prevent it from joining the country's list of viral treatments.
The oral drug, molnupiravir, is said to ultimately stop the replication of the virus by introducing a different mechanism in the genetic material, but it could affect growing human cells.